<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6941257/table_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 3</label>
  <p>A summary of several aptamers developed for the treatment of parasitic infections by SELEX method</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">Organism</th>
   <th colspan="1" rowspan="1" id="0-1-.">Type of aptamer</th>
   <th colspan="1" rowspan="1" id="0-2-.">Target</th>
   <th colspan="1" rowspan="1" id="0-3-.">Aptamer therapeutic effect</th>
   <th colspan="1" rowspan="1" id="0-4-.">Ref</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>
    <i>E. histolytica</i>
   </td>
   <td>RNA</td>
   <td>Polyadenylation factor EhCFIm25</td>
   <td>Inhibited parasite proliferation and led to cell death</td>
   <td>[ 
    <a ref-type="bibr" rid="CR102">102</a>] 
   </td>
  </tr>
  <tr>
   <td>
    <i>L. infantum</i>
   </td>
   <td>DNA</td>
   <td>rLiPABP</td>
   <td>Affecting the physiological role of PABP</td>
   <td>[ 
    <a ref-type="bibr" rid="CR101">101</a>] 
   </td>
  </tr>
  <tr>
   <td>
    <i>P. falciparum</i>
   </td>
   <td>RNA</td>
   <td>EMP1</td>
   <td>Disruption and sequestration of parasites Reduced rosette formation</td>
   <td>[ 
    <a ref-type="bibr" rid="CR99">99</a>] 
   </td>
  </tr>
  <tr>
   <td>
    <i>T. cruzi</i>
   </td>
   <td>RNA</td>
   <td>Cell adhesion</td>
   <td>Inhibit cell invasion</td>
   <td>[ 
    <a ref-type="bibr" rid="CR98">98</a>] 
   </td>
  </tr>
  <tr>
   <td>
    <i>T. brucei</i>
   </td>
   <td>RNA</td>
   <td>VSG proteins</td>
   <td>Directing antibodies to the surface of the parasite</td>
   <td>[ 
    <a ref-type="bibr" rid="CR103">103</a>] 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p>
   <i>rLiPABP</i> recombinant 6xHIS-LiPABP protein, 
   <i>EMP1</i> erythrocyte membrane protein 1, 
   <i>VSG</i> variant surface glycoproteins 
  </p>
 </tfoot>
</table>
